Milan, Italy: Pierre Fabre Pharmaceuticals and BMG Pharma S.r.l announce the signature of a Distribution and Supply Agreement for AFTACURE Gel and AFTACURE Spray in different territories

* Pierre Fabre Oral Care, a brand of Pierre Fabre Pharmaceuticals, is one of the leaders in Europe in oral and dental hygiene products with its ranges of products presented to dentists across Europe  * Thanks to this agreement in line with its open innovation strategy, Pierre Fabre Oral Care expands  and completes its portfolio […]

Read More
Milan, Italy: BMG PHARMA S.r.l announces the achievement of the Certificate for ISO 13485.

Milan, 18th January 2016 BMG Pharma S.r.l. is pleased to announce the achievement of the ISO Certificate 13485 from TÜV Süd. The Certificate issued by TÜV Süd America Inc., USA, certifies that BMG has established and is maintaining a quality management system that meets the requirements of ISO 13485:2003 and is in compliance with the Health […]

Read More
Milan, Italy: BMG PHARMA S.r.l announces the issue of results of clinical studies related to its proprietary products GelX oral Gel and GelX Oral Spray.

Milan, Italy: BMG PHARMA S.r.l announces the issue of results of clinical studies related to its proprietary products GelX oral Gel and GelX Oral Spray.   Milan, 9th November 2015 BMG Pharma S.r.l. is pleased to announce the publication of results of clinical studies related to GelX® Oral Gel and GelX® Oral Spray. GelX® Oral Gel […]

Read More
BMG PHARMA S.r.l announces the signature of a Distribution Agreement for its Cancer Supportive Care line including its iron in liposomal technology based product with Sayre Therapeutics for India and other Asian area countries.

Milan, Italy: BMG PHARMA S.r.l announces the signature of a Distribution Agreement for its Cancer Supportive Care line including its iron in liposomal technology based product with Sayre Therapeutics for India and other Asian area countries. Milan, 30th July 2015 BMG Pharma S.r.l. is pleased to announce the signature of a Distribution Agreement with Sayre […]

Read More
BMG PHARMA S.r.l announces the signature of a Distribution Agreement for its proprietary product IALUXID® Gel with LatAm HQ Health Ltd, UK for the territory of Central and South America. LatAm HQ will also launch in the same territory other BMG proprietary products such as AKENKIT and NASAL SPRAY SOLUTIONS.

Milan, Italy: BMG PHARMA S.r.l  announces the signature of a Distribution Agreement for its proprietary product IALUXID® Gel with LatAm HQ Health Ltd, UK for the territory of Central and South  America. LatAm HQ will also launch in the same territory  other BMG proprietary products such as AKENKIT and  NASAL SPRAY SOLUTIONS Milan, 18th June, […]

Read More
BMG Pharma S.r.l (“BMG”) announces the launch of its proprietary product Ialuxid® Gel under the new trademark HPO Skin Protect owned by Centro Internacional de Cosmiatria, S.A.P.I. de C.V. (“FARMAPIEL”) in Mexico.

Milan, Italy: BMG Pharma S.r.l (“BMG”) announces the launch of its proprietary product Ialuxid® Gel under the new trademark HPO Skin Protect owned by Centro Internacional de Cosmiatria, S.A.P.I. de C.V. (“FARMAPIEL”) in Mexico Milan, 18th May, 2015 BMG Pharma S.r.l. (“BMG”) is pleased to announce that, after the signature of a Supply and Distribution […]

Read More